About this trial
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Between the ages of 50 and 90 years
Free from orthopedic limitations that would prohibit performing leg exercise
BMI < 40 kg/m2 and weigh < 400lbs
Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following SARS-CoV-2 infection
Disqualifiers
Unable to give written informed consent
Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months
Claustrophobia
Orthopedic limitations that would prohibit them from walking
Trial design
Parallel
Treatments tested in this trial
Heat therapy
BehavioralAt home lower body heat therapy
Sham Control
BehavioralSham Thermoneutral
Walking
BehavioralWalking intervention
Treatment groups
Trial outcomes
Primary outcomes
6 min walking distance
Distance covered during 6 min of walking
Short Physical Performance Battery Test
Test of physical functional capacity
Arterial stiffness
Pulse Wave velocity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Nebraska
Lead sponsor
National Institute on Aging (NIA)
Collaborator